Learn more at LeadIQ.com

Insights

Immunotherapy Market Growth Imugene is positioned in the rapidly growing immunotherapy market, offering innovative immunotherapies aiming to activate the immune system against tumors, which aligns with the increasing demand for effective cancer treatments.

Expert Cancer Development Team Imugene boasts a strong team of international cancer experts with a proven track record in developing successful cancer therapies, providing credibility and expertise that can be leveraged to attract potential investors and partners.

Diverse Product Pipeline With a diverse product pipeline encompassing multiple B-cell vaccine candidates and an oncolytic virotherapy targeting various cancers, Imugene has the potential to cater to a wide range of cancer types, offering multiple entry points for collaborations and licensing opportunities.

Strong Financial Position With a revenue range of $10M - 50M and recent funding of $3.3M, Imugene demonstrates financial stability and growth potential, making it an attractive partner for investors looking to invest in a promising biotechnology company.

Technologically Advanced Platform Imugene utilizes a range of advanced technologies such as Facebook Pixel, Squarespace Commerce, and Google Font API, showcasing a commitment to innovation that can be leveraged to create personalized marketing strategies and enhance customer engagement.

Similar companies to Imugene Limited

Imugene Limited Tech Stack

Imugene Limited uses 8 technology products and services including Facebook Pixel, Squarespace Commerce, Google Font API, and more. Explore Imugene Limited's tech stack below.

Facebook Pixel
Analytics
Squarespace Commerce
E-commerce
Google Font API
Font Scripts
jQuery
Javascript Libraries
Choices
Javascript Libraries
RSS
Miscellaneous
Bootstrap
UI Frameworks
YouTube
Video Players

Media & News

Imugene Limited's Email Address Formats

Imugene Limited uses at least 1 format(s):

Imugene Limited Email Formats	Example	Percentage
FLast@imugene.com	JDoe@imugene.com	47%
First.Last@imugene.com	John.Doe@imugene.com	4%
FL@imugene.com	JD@imugene.com	2%
FLast@imugene.com	JDoe@imugene.com	47%

Frequently Asked Questions

Where is Imugene Limited's headquarters located?

Imugene Limited's main headquarters is located at 37 Bligh St Suite 1006, Level 10 Sydney, New South Wales 2000 AU. The company has employees across 3 continents, including North AmericaOceaniaEurope.

What is Imugene Limited's phone number?

You can contact Imugene Limited's main corporate office by phone at

+61-3-9824-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Imugene Limited's official website and social media links?

Imugene Limited's official website is imugene.com and has social profiles on LinkedIn.

How much revenue does Imugene Limited generate?

As of October 2024, Imugene Limited's annual revenue reached $35M.

What is Imugene Limited's SIC code NAICS code?

Imugene Limited's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Imugene Limited have currently?

As of October 2024, Imugene Limited has approximately 58 employees across 3 continents, including North AmericaOceaniaEurope. Key team members include Chief Medical Officer: P. W.Chief Operating Officer: B. G.Chief Medical Officer: M. M.. Explore Imugene Limited's employee directory with LeadIQ.

What industry does Imugene Limited belong to?

Imugene Limited operates in the Biotechnology Research industry.

What technology does Imugene Limited use?

Imugene Limited's tech stack includes Facebook PixelSquarespace CommerceGoogle Font APIjQueryChoicesRSSBootstrapYouTube.

What is Imugene Limited's email format?

Imugene Limited's email format typically follows the pattern of . Find more Imugene Limited email formats with LeadIQ.

How much funding has Imugene Limited raised to date?

As of October 2024, Imugene Limited has raised $3.3M in funding. The last funding round occurred on Sep 03, 2024 for $3.3M.

When was Imugene Limited founded?

Imugene Limited was founded in 2013.

Imugene Limited

Imugene Limited

Biotechnology ResearchNew South Wales, Australia51-200 Employees

Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Our unique platform technologies seek to harness the body’s immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and other immunotherapies. Our product pipeline includes multiple immunotherapy B-cell vaccine candidates and an oncolytic virotherapy (CF33) aimed at treating a variety of cancers in combination with standard of care drugs and emerging immunotherapies. We are supported by a leading team of international cancer experts with extensive experience in developing new cancer therapies with many approved for sale and marketing for global markets. ASX: IMU

Company Overview

Headquarters: 37 Bligh St Suite 1006, Level 10 Sydney, New South Wales 2000 AU
Phone number: ✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+61-3-9824-****
Website: imugene.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2013
Employees: 51-200

Media & News

Funding & Financials

$3.3M
Imugene Limited has raised a total of $3.3M of funding over 3 rounds. Their latest funding round was raised on Sep 03, 2024 in the amount of $3.3M.
$10M$50M
Imugene Limited's revenue is in the range of $10M$50M

Funding & Financials

$3.3M
Imugene Limited has raised a total of $3.3M of funding over 3 rounds. Their latest funding round was raised on Sep 03, 2024 in the amount of $3.3M.
$10M$50M
Imugene Limited's revenue is in the range of $10M$50M

Company Leadership

P. W.
Chief Medical Officer
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. G.
Chief Operating Officer
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. M.
Chief Medical Officer
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. T.
Chief Financial Officer
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. S.
Vice President - Clinical Operations
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

M. T.
Chief Financial Officer
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. A.
Head Of Quality And Supply Operations
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. P.
Vice President, Regulatory Affairs
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. S.
Vice President - Clinical Operations
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. W.
Vice President Of Cmc
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Imugene Limited and Millions of Other Companies
Sign up for full access to Imugene Limited information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.